Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development
Rare monogenic disorders such as lysosomal diseases have been at the forefront in the development of novel treatments where therapeutic options are either limited or unavailable. The increasing number of successful pre-clinical and clinical studies in the last decade demonstrates that gene therapy r...
Main Authors: | Giulia Massaro, Amy F. Geard, Wenfei Liu, Oliver Coombe-Tennant, Simon N. Waddington, Julien Baruteau, Paul Gissen, Ahad A. Rahim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/4/611 |
Similar Items
-
Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial–Lysosomal Axis
by: Myeong Uk Kuk, et al.
Published: (2021-02-01) -
The rapidly evolving view of lysosomal storage diseases
by: Giancarlo Parenti, et al.
Published: (2021-02-01) -
Lysosomal Storage Disorders and Malignancy
by: Gregory M. Pastores, et al.
Published: (2017-02-01) -
1,8-Naphthalimide-Based Multifunctional Compounds as Cu2+ Probes, Lysosome Staining Agents, and Non-viral Vectors
by: Yong-Guang Gao, et al.
Published: (2019-09-01) -
Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders
by: Brunella Tancini, et al.
Published: (2019-07-01)